The UArizona Steele Children's Research Center was selected by Angel Charity for Children to receive $800,000 in funding to help children in need in Tucson.

A compound developed by researchers at the R. Ken Coit College of Pharmacy moves one step closer to commercialization with licensing agreement.

Ivo Abraham, PhD, professor of practice in the R. Ken Coit College of Pharmacy, details how biosimilar guidelines from the World Health Organization have changed over time and whether those changes are beneficial for biosimilars.

Stricter rules for patients and doctors who use telemedicine could soon become reality. The DEA recently proposed rules that would require patients to see a doctor in person before they could receive treatment for an attention deficit disorder or be prescribed things like painkillers.

An article about alternative medicine infiltrating mainstream health care mentions the research of Gary Schwartz, professor of psychology in the UArizona College of Science with additional appointments in the College of Medicine – Tucson.

Researchers at the R. Ken Coit College of Pharmacy have been developing and measuring the effectiveness of a new compound that inhibits SARS-CoV-2, the virus that causes COVID-19, and the university has exclusively licensed the technology to Sunshine Biopharma Inc. to take the technology forward for further development and testing.

The University of Arizona Health Sciences Primary Care Physician Scholarship program is designed to fill Arizona’s increasing need for primary care providers.

The goal of the conference is to improve patient outcomes by sharing knowledge with primary care providers and others interested in mental health concerns.

The pandemic changed the way we think about illness — whether we go into a full-blown panic when a coworker sneezes or have developed a fear of leaving the house. And while a lot of us are able to return to the world in this phase of COVID-19 easily enough, a lot of people can’t.